These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29695963)

  • 1. The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice.
    Schafer C; Moore V; Dasgupta N; Javadov S; James JF; Glukhov AI; Strauss AW; Khuchua Z
    Front Pharmacol; 2018; 9():318. PubMed ID: 29695963
    [No Abstract]   [Full Text] [Related]  

  • 2. The PPAR pan-agonist bezafibrate ameliorates cardiomyopathy in a mouse model of Barth syndrome.
    Huang Y; Powers C; Moore V; Schafer C; Ren M; Phoon CK; James JF; Glukhov AV; Javadov S; Vaz FM; Jefferies JL; Strauss AW; Khuchua Z
    Orphanet J Rare Dis; 2017 Mar; 12(1):49. PubMed ID: 28279226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barth syndrome-related cardiomyopathy is associated with a reduction in myocardial glucose oxidation.
    Greenwell AA; Gopal K; Altamimi TR; Saed CT; Wang F; Tabatabaei Dakhili SA; Ho KL; Zhang L; Eaton F; Kruger J; Al Batran R; Lopaschuk GD; Oudit GY; Ussher JR
    Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2255-H2269. PubMed ID: 33929899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endurance training ameliorates complex 3 deficiency in a mouse model of Barth syndrome.
    Soustek MS; Baligand C; Falk DJ; Walter GA; Lewin AS; Byrne BJ
    J Inherit Metab Dis; 2015 Sep; 38(5):915-22. PubMed ID: 25860817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulating myocardial pyruvate dehydrogenase activity fails to alleviate cardiac abnormalities in a mouse model of human Barth syndrome.
    Greenwell AA; Tabatabaei Dakhili SA; Gopal K; Saed CT; Chan JSF; Kazungu Mugabo N; Zhabyeyev P; Eaton F; Kruger J; Oudit GY; Ussher JR
    Front Cardiovasc Med; 2022; 9():997352. PubMed ID: 36211560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tafazzin knockdown in mice leads to a developmental cardiomyopathy with early diastolic dysfunction preceding myocardial noncompaction.
    Phoon CK; Acehan D; Schlame M; Stokes DL; Edelman-Novemsky I; Yu D; Xu Y; Viswanathan N; Ren M
    J Am Heart Assoc; 2012 Apr; 1(2):. PubMed ID: 23130124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted overexpression of catalase to mitochondria does not prevent cardioskeletal myopathy in Barth syndrome.
    Johnson JM; Ferrara PJ; Verkerke ARP; Coleman CB; Wentzler EJ; Neufer PD; Kew KA; de Castro Brás LE; Funai K
    J Mol Cell Cardiol; 2018 Aug; 121():94-102. PubMed ID: 30008435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A critical appraisal of the tafazzin knockdown mouse model of Barth syndrome: what have we learned about pathogenesis and potential treatments?
    Ren M; Miller PC; Schlame M; Phoon CKL
    Am J Physiol Heart Circ Physiol; 2019 Dec; 317(6):H1183-H1193. PubMed ID: 31603701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiolipin deficiency in Barth syndrome is not associated with increased superoxide/H
    Goncalves RLS; Schlame M; Bartelt A; Brand MD; Hotamışlıgil GS
    FEBS Lett; 2021 Feb; 595(3):415-432. PubMed ID: 33112430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myokine Musclin Is Critical for Exercise-Induced Cardiac Conditioning.
    Harris MP; Zeng S; Zhu Z; Lira VA; Yu L; Hodgson-Zingman DM; Zingman LV
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Influence of Supplemental Dietary Linoleic Acid on Skeletal Muscle Contractile Function in a Rodent Model of Barth Syndrome.
    Elkes M; Andonovski M; Vidal D; Farago M; Modafferi R; Claypool SM; LeBlanc PJ
    Front Physiol; 2021; 12():731961. PubMed ID: 34489741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency.
    Soustek MS; Falk DJ; Mah CS; Toth MJ; Schlame M; Lewin AS; Byrne BJ
    Hum Gene Ther; 2011 Jul; 22(7):865-71. PubMed ID: 21091282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tafazzin deficiency in mouse mesenchymal stem cells promote reprogramming of activated B lymphocytes toward immunosuppressive phenotypes.
    Zegallai HM; Abu-El-Rub E; Olayinka-Adefemi F; Cole LK; Sparagna GC; Marshall AJ; Hatch GM
    FASEB J; 2022 Aug; 36(8):e22443. PubMed ID: 35816277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished Exercise Capacity and Mitochondrial bc1 Complex Deficiency in Tafazzin-Knockdown Mice.
    Powers C; Huang Y; Strauss A; Khuchua Z
    Front Physiol; 2013; 4():74. PubMed ID: 23616771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The IkappaBalpha gene is a peroxisome proliferator-activated receptor cardiac target gene.
    Buroker NE; Barboza J; Huang JY
    FEBS J; 2009 Jun; 276(12):3247-55. PubMed ID: 19438714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the Beneficial Role of PPAR Agonists in Cardiac Diseases.
    Khuchua Z; Glukhov AI; Strauss AW; Javadov S
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tafazzin deficiency in mouse mesenchymal stem cells potentiates their immunosuppression and impairs activated B lymphocyte immune function.
    Zegallai HM; Abu-El-Rub E; Olayinka-Adefemi F; Cole LK; Sparagna GC; Marshall AJ; Hatch GM
    bioRxiv; 2021 Sep; ():. PubMed ID: 34729562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Musclin is an activity-stimulated myokine that enhances physical endurance.
    Subbotina E; Sierra A; Zhu Z; Gao Z; Koganti SR; Reyes S; Stepniak E; Walsh SA; Acevedo MR; Perez-Terzic CM; Hodgson-Zingman DM; Zingman LV
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):16042-7. PubMed ID: 26668395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
    Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
    Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.